Literature DB >> 34668231

Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study.

Jamie K Capal1,2,3, Marian E Williams4, Deborah A Pearson5, Robin Kissinger4, Paul S Horn2,3, Donna Murray3,6,7, Kristn Currans8, Bridget Kent6, Martina Bebin9, Hope Northrup5, Joyce Y Wu10, Mustafa Sahin11, Darcy A Krueger2,3.   

Abstract

OBJECTIVE: Tuberous sclerosis complex (TSC) is highly associated with autism spectrum disorder (ASD). Objectives of the study were to characterize autistic features in young children with TSC.
METHODS: Participants included 138 children followed from ages 3 to 36 months with TSC from the Tuberous Sclerosis Complex Autism Center of Excellence Research Network (TACERN), a multicenter, prospective observational study aimed at understanding the underlying mechanisms of ASD in TSC. Developmental and autism-specific assessments were administered, and a clinical diagnosis of ASD was determined for all participants at 36 months. Further analyses were performed on 117 participants with valid autism assessments based on nonverbal mental age greater than 15 months.
RESULTS: Prevalence of clinical diagnosis of ASD at 36 months was 25%. Nearly all autistic behaviors on the Autism Diagnostic Observation Schedule-2 (ADOS-2) and Autism Diagnostic Interview-Revised (ADI-R) were more prevalent in children diagnosed with ASD; however, autism-specific behaviors were also observed in children without ASD. Overall quality of social overtures, facial expressions, and abnormal repetitive interests and behaviors were characteristics most likely to distinguish children with ASD from those without an ASD diagnosis. Participants meeting ADOS-2 criteria but not a clinical ASD diagnosis exhibited intermediate developmental and ADOS-2 scores compared to individuals with and without ASD.
INTERPRETATION: ASD is highly prevalent in TSC, and many additional individuals with TSC exhibit a broad range of subthreshold autistic behaviors. Our findings reveal a broader autism phenotype that can be identified in young children with TSC, which provides opportunity for early targeted treatments. ANN NEUROL 2021;90:874-886.
© 2021 American Neurological Association.

Entities:  

Mesh:

Year:  2021        PMID: 34668231      PMCID: PMC8639652          DOI: 10.1002/ana.26249

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  40 in total

Review 1.  Consensus clinical guidelines for the assessment of cognitive and behavioural problems in Tuberous Sclerosis.

Authors:  Petrus de Vries; Ayla Humphrey; Deborah McCartney; Penny Prather; Patrick Bolton; Ann Hunt
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-07       Impact factor: 4.785

2.  Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex.

Authors:  Shafali Spurling Jeste; Joyce Y Wu; Damla Senturk; Kandice Varcin; Jordan Ko; Brigid McCarthy; Christina Shimizu; Kira Dies; Vanessa Vogel-Farley; Mustafa Sahin; Charles A Nelson
Journal:  Neurology       Date:  2014-06-11       Impact factor: 9.910

Review 3.  Mechanism-based treatment in tuberous sclerosis complex.

Authors:  Kristina Jülich; Mustafa Sahin
Journal:  Pediatr Neurol       Date:  2013-12-05       Impact factor: 3.372

Review 4.  Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism.

Authors:  Peter E Davis; Jurriaan M Peters; Darcy A Krueger; Mustafa Sahin
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 5.  Evolving neurobiology of tuberous sclerosis complex.

Authors:  Peter B Crino
Journal:  Acta Neuropathol       Date:  2013-02-06       Impact factor: 17.088

6.  Autism Phenotypes in Tuberous Sclerosis Complex: Diagnostic and Treatment Considerations.

Authors:  Tanjala T Gipson; Andrea Poretti; Emily A Thomas; Kosunique T Jenkins; Sonal Desai; Michael V Johnston
Journal:  J Child Neurol       Date:  2015-08-24       Impact factor: 1.987

7.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10

8.  Corpus Callosum White Matter Diffusivity Reflects Cumulative Neurological Comorbidity in Tuberous Sclerosis Complex.

Authors:  Fiona M Baumer; Jurriaan M Peters; Sean Clancy; Anna K Prohl; Sanjay P Prabhu; Benoit Scherrer; Floor E Jansen; Kees P J Braun; Mustafa Sahin; Aymeric Stamm; Simon K Warfield
Journal:  Cereb Cortex       Date:  2018-10-01       Impact factor: 5.357

Review 9.  Autism in tuberous sclerosis.

Authors:  Paolo Curatolo; Maria Cristina Porfirio; Barbara Manzi; Stefano Seri
Journal:  Eur J Paediatr Neurol       Date:  2004       Impact factor: 3.140

10.  Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016.

Authors:  Matthew J Maenner; Kelly A Shaw; Jon Baio; Anita Washington; Mary Patrick; Monica DiRienzo; Deborah L Christensen; Lisa D Wiggins; Sydney Pettygrove; Jennifer G Andrews; Maya Lopez; Allison Hudson; Thaer Baroud; Yvette Schwenk; Tiffany White; Cordelia Robinson Rosenberg; Li-Ching Lee; Rebecca A Harrington; Margaret Huston; Amy Hewitt; Amy Esler; Jennifer Hall-Lande; Jenny N Poynter; Libby Hallas-Muchow; John N Constantino; Robert T Fitzgerald; Walter Zahorodny; Josephine Shenouda; Julie L Daniels; Zachary Warren; Alison Vehorn; Angelica Salinas; Maureen S Durkin; Patricia M Dietz
Journal:  MMWR Surveill Summ       Date:  2020-03-27
View more
  2 in total

1.  miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex.

Authors:  Mirte Scheper; Alessia Romagnolo; Zein Mersini Besharat; Anand M Iyer; Romina Moavero; Christoph Hertzberg; Bernhard Weschke; Kate Riney; Martha Feucht; Theresa Scholl; Borivoj Petrak; Alice Maulisova; Rima Nabbout; Anna C Jansen; Floor E Jansen; Lieven Lagae; Malgorzata Urbanska; Elisabetta Ferretti; Aleksandra Tempes; Magdalena Blazejczyk; Jacek Jaworski; David J Kwiatkowski; Sergiusz Jozwiak; Katarzyna Kotulska; Krzysztof Sadowski; Julita Borkowska; Paolo Curatolo; James D Mills; Eleonora Aronica
Journal:  Biomedicines       Date:  2022-07-29

Review 2.  Using causal methods to map symptoms to brain circuits in neurodevelopment disorders: moving from identifying correlates to developing treatments.

Authors:  Alexander Li Cohen
Journal:  J Neurodev Disord       Date:  2022-03-12       Impact factor: 4.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.